pat_auckland said:

The mechanism is slowed transit plus reduced intake, and that combination determines which interventions work.

Bookmarking. The distinction being drawn above is the one nobody else makes.

Clinical perspective, offered as context rather than as advice.

Gastric emptying studies and constipation: semaglutide delays gastric emptying by ~40% at steady state, as measured by acetaminophen absorption testing and scintigraphy[1].

Clinically relevant implications:

• Explains early satiety and nausea
• Affects absorption of co-administered oral medications
• Creates aspiration risk for procedures under anesthesia
• Contributes to constipation via slowed GI transit

Importantly, the gastric emptying delay attenuates with continued use (tachyphylaxis), which correlates with the transient nature of GI side effects.

Dr.AddMedPHL said:

The gap between trial results and real-world results is consistent and it is not fraud.

Pushing back on Dr.AddMedPHL here. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.

Dr.GutHealth said:

The escalation order that reflects the mechanism: water and salt first, then soluble fiber, then magnesium or an osmotic agent, then a stimulant only…

Drug interaction alert relevant to constipation: if you take oral levothyroxine (Synthroid), GLP-1 agonists can reduce absorption due to delayed gastric emptying. My TSH drifted up after starting semaglutide.

Solution: take levothyroxine on an empty stomach, 60 minutes before any food, and have your TSH rechecked 6-8 weeks after starting or changing GLP-1 dose. My endo had to increase my Synthroid by 12.5mcg.

Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again.